Articles

How does Vietnam's work on a seasonal influenza vaccine mitigate deadly pandemics?

Vietnam has been working for nearly a decade to develop and manufacture influenza vaccines. With PATH support, the Institute of Vaccines and Medical Biologicals has done just that—and it has submitted two candidates for licensure.

As a nine-year project to build vaccine development capacity worldwide comes to an end, PATH and partners reflect on how far we’ve come.

An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 20-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached more than 300 million children—a turning point in the battle to protect people from this dreaded disease.